Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 2 from your keywords: author="Gurbel PA"
cover
Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatele…
Comment Share
Gurbel PA

Ticagrelor is the first reversibly binding oral P2Y12 receptor antagonist. This is the first study to compare the onset and offset of platelet inhibition (IPA) with ticagrelor using the PLATO (PLATelet inhibition and patient Outcomes) trial loading dose (180 mg) with a high loading dose (600 mg) of clopidogrel

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect…
Comment Share
Gurbel PA

The antiplatelet effects of the Platelet Inhibition and Patient Outcomes (PLATO) trial dose of ticagrelor in patients nonresponsive to clopidogrel and after they switch agents are unknown

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-